Watchmaker: Watchmaker Genomics Announces Launch of Cost-effective RNase Inhibitor for Single-cell, Single-nuclei, and Pathogen Detection Applications

BOULDER, Colo.--(BUSINESS WIRE)-- #NGS--Watchmaker Genomics, a provider of innovative solutions for molecular analysis, announced the launch of a high-purity RNase Inhibitor that is well-suited for a wide range of applications where maintaining RNA integrity is critical, including single-cell and single-nuclei sequencing, as well as pathogen detection. "We are pleased to bring our RNase Inhibitor to market," said Sandra Rowe, Vice President of Marketing at Watchmaker. "We aim to be a partner for our c